134 related articles for article (PubMed ID: 31736244)
1. Malignancy and lymphoid proliferation in primary immune deficiencies; hard to define, hard to treat.
Kiykim A; Eker N; Surekli O; Nain E; Kasap N; Aktürk H; Dogru O; Canbolat A; Somer A; Koc A; Tokuc G; Bozkurt S; Turkoz K; Karakoc-Aydiner E; Ozen A; Baris S
Pediatr Blood Cancer; 2020 Feb; 67(2):e28091. PubMed ID: 31736244
[TBL] [Abstract][Full Text] [Related]
2. The evaluation of malignancies in Turkish primary immunodeficiency patients; a multicenter study.
Cekic S; Metin A; Aytekin C; Edeer Karaca N; Baris S; Karali Y; Kiykim A; Karakoc Aydıner E; Ozen A; Aslan T; Sevinir B; Aksu G; Kutukculer N; Kilic SS
Pediatr Allergy Immunol; 2020 Jul; 31(5):528-536. PubMed ID: 32060950
[TBL] [Abstract][Full Text] [Related]
3. Primary Immunodeficiency and Cancer in Children; A Review of the Literature.
Kebudi R; Kiykim A; Sahin MK
Curr Pediatr Rev; 2019; 15(4):245-250. PubMed ID: 31530267
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune and inflammatory manifestations in pediatric patients with primary immunodeficiencies and their importance as a warning sign.
Kaplan MY; Ozen S; Akcal O; Gulez N; Genel F
Allergol Immunopathol (Madr); 2020; 48(6):701-710. PubMed ID: 32446782
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of proliferative lesions of haematopoietic and lymphoid tissue in the female productive tract].
Chen DB; Zhang H; Zhang YH; Wang Y; Song QJ; Yang SM; Cui H; Zhao Y; Fang XZ; Shen DH
Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):263-269. PubMed ID: 29747272
[No Abstract] [Full Text] [Related]
6. Clinical Profile and Outcomes of Primary Immunodeficiency and Malignancy in Childhood at a Tertiary Oncology Center in Developing Country.
Özyörük D; Güzelküçük Z; Metin A; Emir S; Yazal Erdem A; Kacar D; Koca Yozgat A; Aker CB; Çakmakçı S; Özdemir SI; Sari N; Cihan MK; Özbek NY; İlhan İE
Pediatr Hematol Oncol; 2022 Oct; 39(7):600-612. PubMed ID: 35282762
[TBL] [Abstract][Full Text] [Related]
7. Malignancies and Lymphoproliferations in Children With Primary Immune Deficiency-A Single-center Experience.
Aydogmus C; Turkyilmaz Ucar O; Kaplan Sarikavak S; Cipe F; Ulas S; Turan I; Naiboglu S; Yildirim I; Kalay G; Kapci N; Al S; Gokmirza Ozdemir P; Celiksoy MH
J Pediatr Hematol Oncol; 2024 Mar; 46(2):e169-e173. PubMed ID: 38277623
[TBL] [Abstract][Full Text] [Related]
8. Activated Phosphoinositide 3 Kinase Delta Syndrome (APDS): A Primary Immunodeficiency Mimicking Lymphoma.
Baleydier F; Ranza E; Schäppi M; Rougemont AL; Merlini L; Ansari M; Blanchard-Rohner G
J Pediatr Hematol Oncol; 2019 Nov; 41(8):e521-e524. PubMed ID: 30334905
[TBL] [Abstract][Full Text] [Related]
9. Differential diagnosis of malignant and benign cutaneous lymphoid infiltrates: a study of 57 cases in which malignant lymphoma had been diagnosed or suspected in the skin.
Evans HL; Winkelmann RK; Banks PM
Cancer; 1979 Aug; 44(2):699-717. PubMed ID: 582573
[TBL] [Abstract][Full Text] [Related]
10. Lymphoma Secondary to Congenital and Acquired Immunodeficiency Syndromes at a Turkish Pediatric Oncology Center.
Tanyildiz HG; Dincaslan H; Yavuz G; Unal E; Ikinciogulları A; Dogu F; Tacyildiz N
J Clin Immunol; 2016 Oct; 36(7):667-76. PubMed ID: 27492260
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological features of splenic tumours of lymphoid tissue.
Chen DB; Shen DH; Yang SM; Fang XZ
Pathol Res Pract; 2018 Dec; 214(12):1952-1958. PubMed ID: 30087035
[TBL] [Abstract][Full Text] [Related]
12. The World Health Organization classification of malignant lymphoma: incidence and clinical prognosis in HTLV-1-endemic area of Fukuoka.
Ohshima K; Suzumiya J; Kikuchi M
Pathol Int; 2002 Jan; 52(1):1-12. PubMed ID: 11940200
[TBL] [Abstract][Full Text] [Related]
13. Lymphoproliferative conditions of the serosa.
Attanoos R
Arch Pathol Lab Med; 2012 Mar; 136(3):268-76. PubMed ID: 22372903
[TBL] [Abstract][Full Text] [Related]
14. Skin disorders are prominent features in primary immunodeficiency diseases: A systematic overview of current data.
de Wit J; Brada RJK; van Veldhuizen J; Dalm VASH; Pasmans SGMA
Allergy; 2019 Mar; 74(3):464-482. PubMed ID: 30480813
[TBL] [Abstract][Full Text] [Related]
15. Thyroid neoplasms after therapeutic radiation for malignancies during childhood or adolescence.
Acharya S; Sarafoglou K; LaQuaglia M; Lindsley S; Gerald W; Wollner N; Tan C; Sklar C
Cancer; 2003 May; 97(10):2397-403. PubMed ID: 12733137
[TBL] [Abstract][Full Text] [Related]
16. Primary gastrointestinal lymphoma in childhood (up to 18 years of age). A morphological, immunohistochemical and clinical study.
Takahashi H; Hansmann ML
J Cancer Res Clin Oncol; 1990; 116(2):190-6. PubMed ID: 2324163
[TBL] [Abstract][Full Text] [Related]
17. Primary malignant skin tumors in children: etiology, treatment and prognosis.
Varan A; Gököz A; Akyüz C; Kutluk T; Yalçin B; Köksal Y; Büyükpamukçu M
Pediatr Int; 2005 Dec; 47(6):653-7. PubMed ID: 16354219
[TBL] [Abstract][Full Text] [Related]
18. Anatomic distribution, clinical features, and survival data of 87 cases primary gastrointestinal lymphoma.
Ge Z; Liu Z; Hu X
World J Surg Oncol; 2016 Mar; 14():85. PubMed ID: 26988370
[TBL] [Abstract][Full Text] [Related]
19. Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center.
Mora J; Filippa DA; Qin J; Wollner N
Cancer; 2003 Sep; 98(6):1283-91. PubMed ID: 12973853
[TBL] [Abstract][Full Text] [Related]
20. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]